Carla Ribeiro is Associate Professor Viral Immunity & Molecular Life Sciences at Amsterdam UMC, location AMC. She is Principal Investigator at the Department of Experimental Immunology and heads the Autophagy-directed Immunity (ADI) group. Her research group focuses on host-virus interactions, aiming to maximize the therapeutic potential of targeting autophagy mechanisms to intervene in HIV-1, Dengue virus and SARS-CoV-2 infections. She also ventures into development of advanced human mucosal models, including intestine and skin tissue infection models and gut organoid co-culture systems. Her group utilizes human organoid technology and patient cohort studies to define the impact of antiviral immune mechanisms and mucosal inflammation in clinical outcomes, and as rationale for drug development. Within GUTVIBRATIONS, Carla is the leader of Work Package 3 (DEFEND) and will be supervising postdoctoral researcher Athanasios Koulis. Here, we aim to build a next-generation gut-mucosal co-culture organoid model that recapitulates the in vivo intestinal physiology and intestinal immune responses.
Amsterdam University Medical Centers (Amsterdam UMC) is one of the foremost research institutions in the Netherlands and one of its largest hospitals, with 1500 staff members employed in medical research. The Amsterdam UMC research is organized in 7 themes within the AMC Research Institute, where AMC Principal Investigators (PIs) are appointed to develop their own research lines. The AMC Graduate School organizes doctorate level academic training of AMC PhD students (209 PhD rewarded in 2016). This concentration of expertise makes the center a breeding ground for fruitful scientific collaborations.